DigiTx Partners

DigiTx Partners is an early-stage venture capital firm established in 2018, operating as a strategic investment vehicle of Mitsui & Co. Global Investment, Inc. Based in Brisbane, California, the firm specializes exclusively in digital health, targeting innovative companies across a broad spectrum of the sector. Their investment focus includes digital therapeutics, AI/ML applications in healthcare, remote monitoring, telemedicine, software as a medical device (SaMD), and solutions for value-based care and patient engagement. This strategic backing from Mitsui provides DigiTx Partners with not only capital but also a global network and deep industry insights, offering significant value-add to their portfolio companies.

The firm successfully raised its inaugural fund, DigiTx Partners Fund I, with a substantial $150 million in committed capital. This fund is primarily deployed across Seed, Series A, and Series B rounds, indicating a commitment to supporting companies through critical early growth phases. DigiTx Partners seeks to invest in disruptive technologies and business models that aim to improve patient outcomes, enhance healthcare efficiency, and drive the transition towards more personalized and value-driven care. Their investment thesis emphasizes the convergence of healthcare and technology to solve pressing industry challenges.

DigiTx Partners has built a notable portfolio of digital health innovators. Key investments include Omada Health, a leading digital care program for chronic conditions, and Livongo, a prominent health platform that was later acquired by Teladoc for $18.5 billion. While some investments, like Pear Therapeutics, faced challenges, their portfolio demonstrates a willingness to back ambitious ventures in emerging digital health categories. With over 25 companies in their portfolio, DigiTx Partners remains an active and influential investor in the rapidly evolving digital health landscape, leveraging its strategic position to foster innovation and growth.